Listed

Five Point Holdings, LLC: Form 10-Q for the period ended Sep 30, 2020

Filed with the SEC on Nov 9, 2020 and accepted by EDGAR at Nov 6, 2020, 23:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-07-01 to 2020-09-30$8.1mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2020-01-01 to 2020-09-30$41.0mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Selling, general and administrative3 months2020-07-01 to 2020-09-30$17.7mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2020-01-01 to 2020-09-30$58.6mus-gaap:SellingGeneralAndAdministrativeExpense
Income tax3 months2020-07-01 to 2020-09-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax9 months2020-01-01 to 2020-09-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-07-01 to 2020-09-30$17.0mus-gaap:NetIncomeLoss
Net income9 months2020-01-01 to 2020-09-30−$1.2mus-gaap:NetIncomeLoss
Operating cash flow9 months2020-01-01 to 2020-09-30−$115.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2020-01-01 to 2020-09-30$2.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-09-30$270.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Total assetsAt period end2020-09-30$2.96bnus-gaap:Assets
Total liabilitiesAt period end2020-09-30$1.06bnus-gaap:Liabilities
Shareholders' equityAt period end2020-09-30$1.88bnus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001574197-20-000028. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.